Primary Prevention of Cardiovascular Disease
Key Points
Key Points
- The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.
- A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions.
- Adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In addition, assessing for other risk-enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning.
- All adults should consume a healthy diet that emphasizes the intake of vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, processed meats, refined carbohydrates, and sweetened beverages. For adults with overweight and obesity, counseling and caloric restriction are recommended for achieving and maintaining weight loss.
- Adults should engage in at least 150 minutes per week of accumulated moderate-intensity physical activity or 75 minutes per week of vigorous-intensity physical activity.
- For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary habits and achieving exercise recommendations, are crucial. If medication is indicated, metformin is first-line therapy, followed by consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
- All adults should be assessed at every healthcare visit for tobacco use, and those who use tobacco should be assisted and strongly advised to quit.
- Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit.
- Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, those who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion.
- Nonpharmacological interventions are recommended for all adults with elevated blood pressure or hypertension. For those requiring pharmacological therapy, the target blood pressure should generally be <130/80 mm Hg.
Treatment
...Treatment...
...Overarching Recommendatio...
...Patient-Cent...
...am-based care approach is recommende...
...ecision-making should guide discussions abo...
...nts of health should inform optimal implem...
...Assessment of...
...dults 40 to 75 years of age, clinicians should...
...o 39 years of age, it is reasonable to asses...
...lts at borderline risk (5% to
...intermediate risk (≥7.5% to...
...20 to 39 years of age and for those 40 to...
...Example Considerations for Address...
...hancing Factors for Clinician–Patient Risk Discu...
...Life...
...Nutrition a...
...emphasizing intake of vegetables, fru...
...nt of saturated fat with dietary monounsaturate...
A diet containing reduced amounts of choles...
...art of a healthy diet, it is reaso...
As a part of a healthy diet, the intake of tra...
...Exercise...
...e routinely counseled in healthcare...
...gage in at least 150 minutes per week of...
...able to meet the minimum physical...
Decreasing sedentary behavior in ad...
...e 3. Definitions and Examples of Di...
...gure 1. Hours Per Day Spent in Vario...
...Other Factors...
...Adults With O...
In individuals with overweight and obesity, weigh...
...unseling and comprehensive lifestyle interventio...
...culating body mass index (BMI) is re...
...reasonable to measure waist circumferen...
...Adults With...
...all adults with T2DM, a tailored nutrit...
...ults with T2DM should perform at l...
...ith T2DM, it is reasonable to initiate metformin...
...r adults with T2DM and additional ASC...
...Treatment of T2DM for Primary Preventi...
Adults...
...dults at intermediate risk (≥7.5%...
...rmediate risk (≥7.5% to
...40 to 75 years of age with diabetes, regardl...
...atients 20 to 75 years of age with a...
...th diabetes mellitus who have multiple ASCVD...
In intermediate-risk (≥7.5%...
...n intermediate-risk (≥7....
...ients at borderline risk (5% to...
...Diabetes-Specific Risk Enhancers T...
...5. Selected Examples of Candidates for Coronary A...
...igure 3. Primary Prevent...
...ble 6. Risk-Enhancing Factors for Clinician–...
...Adult...
...ults with elevated blood pressure (BP) or hype...
...olic BP (SBP) of 130 mm Hg or highe...
...diastolic BP (DBP) of 80 mm Hg or higher,...
...erage systolic BP (SBP) of 130 or less...
...stolic BP (DBP) of 80 mm Hg or less (I...
...average systolic BP (SBP) of 130 or less (I, B...
...average diastolic BP (DBP) of 80 mm Hg or...
...tolic BP (SBP) of 130 or less (I,...
...stolic BP (DBP) of 80 mm Hg or less...
...ith an estimated 10-year ASCVD risk...
...ge systolic BP (SBP) of 130 or less (IIb, B-N...
...olic BP (DBP) of 80 mm Hg or less (...
...rom recommendations in the 2017 Hyper...
...Thresholds and Recommendations for Tr...
...Proven Nonpharmacological Interventions...
...Treatment...
...should be assessed at every healthcare visit...
...co abstinence, all adults who use tobacco shou...
...use tobacco, a combination of behavioral interven...
...s who use tobacco, tobacco abstinence is...
...bacco cessation, it is reasonable to dedicate...
...dolescents should avoid secondhand smoke ex...
...le 8. Highlights of Recommended Behavioral and Pha...
...Aspirin Use...
...aspirin (75–100 mg orally daily)...
...(75–100 mg orally daily) should NOT be admi...
...e aspirin (75–100 mg orally daily) should NOT b...